A. Congenital hypothyroidism detected by s screening program with specimen collection at two time periods.
The Northwest (U.S.) Regional ScreeninR Program (NWRSP) for congenital hypothyroidism (CH) employs a primary T4 screen with TSH backup. Heel prick filter paper specimens are routinely collected at 2 time periods : days 1-7 of life and 2-6 weeka of age. Between 5/75 and 3/81, 470, 750 infants were tested on the first specimen, while 266,200 were tested on the second specimen. 101 infants were detected with primary hypothyroidism (1:4660), 2 infants had hypopituitary hypothyroidism, while 78 infants were detected with congenital THG deficiency ( 1: 6035) . Of the 101 infants, 90 were detected with a low T4 snd elevated TSH on the first specimen (1 :5,230), while 11 infants were discovered with s low T4 and high TSH on the second routine specimen (1:24,200). Of these 11 infants, 7 had a T4 concentration above the 3~cutoff on the initial specimen while the other 4 had a T4 bel~1 the cutoff, but their TSH concentrations were below the level of sensitivity of the TSH assay (usually <25~V/nl) .~c 99n scans done in 9 of 11 infants showed some residual thvroid tissue in 8 of 9 ca s es . Six of 7 infsnts hsd normal skeletai maturation on X-r a" studies. We conclude that 10% of infants with CH appear to have an evolving hypothyroidism which is detected only by a second routine screening test at 2-6 weeks of age. The frequency of detection of CH on the second r outine specimen has proven cost-effective in the NWRSP. 2 P ROCHICCIOLI, JP FARRIAUX*. ML BRIARo*. R BOSCHETTI* CHU Rangu~il Toulouse France. Neonatal screening of hypothyroidism in France. Results of screeninq : 1.300.000 infants. The neonatal screening of hypothyroidism started in France in 1975 in a few districts. then progressively extented to the whole country In 19BO the testing rate is 96.9%. 1.324.00)infants ha,ve been tested ana 320 hypothyroidism detected. The inci dence is 1/3200. Thvroid scanner (Tc 99 or I 123) revealed ectopia in 54%. athyreosis in '0% an rl gl~nd in normal place in 16% . TSH levels are above 100 U/ml in most~ases. The control of :4 was ma~in 167 cases. T4 levels is 1.27-0.8 Il9ldl In athyreos is and 3,9-7.6 In ectopia (p< 0.001). In 23 ectopia the T4 levels is normal. above 51l9/dl. A study of clinical score 3nd bone matu~at ion took~Iace i~1R.8+hypothy-roidi sm. The clinical score is 2,9-1 in athyreOSIs and 1,7-1,2 in ectopia (p( 0,001). we found a correlation between clinical score, T4 levels and T3 levels (p~O.O~). The epiphysis area (Knee) is 6,4 -10 mm2 in athyreosis and 20,6-11 In ectnpld (p~0,001). There IS a correlation between epiphysis area, clinical score. T4 levels and T3 levels (p(0.05). Psycho-motor development (Brunet-Lezine Test), with a 3 years survey. was only studied in 30 hypothyroidism follo~in I~idi-Pyr{>~es district.. The global QO is respectivaly 101-9. 96!8 and 99"10 at the age of 6, 18 and 36 months. part~al CD are normal at 6 months but langage and sociability crop at BR-12 at. months . and a aifference is found between athyreos is and ectopiaf or all partial Qo at this age. These results allow us to find thẽ t~~theR£:s known between ectopia and athyreosis in s~ite on early centiles of T4,FT4 and TBG remain rather 8table throughout the study around birth levels at 4-5 pq I/dl,I.S ng/dl and 2 mq/dl respectively .Patients have significantly lower levels of T4,FT4, T3 and TBG at birth and at day 10;Tq is significantly lower at birth; 'T3 at day 10. T3 treatment results in increased levels of T3 and TBG and lowered T4,FT4 and rT3.T4 treatment is associated with low TBG and T3 levels despi t eo normal l eve ls of T4, FT4 and rT3. No significant differences in TSH levels are found.
These data suggest that in some pre-term in fa nts an "euthyroid lick syndrome"miqht exist for some time after birth ; thyroid hormone therapy might coun t e r a c t failure to thrive.
B. WOlF·, P. ezERNI~, N. ETUt«;·, R. POI14REDE", 4 R. RAPPAPORT. H&pital del Enfants-Halades, Paris. 24h variation af T4, FT4, T3 and TSH after a lingle oral dose of I-T4 in congenital hypothyroidisM.
Knowledge of plas-a variation of thyroid parameters is important for blood saMpling during evaluation of I-T4 treatment. 11 children, aged 2 to 12 Months, treated with a single aral dose of I-T4 at 8 aM (5 to 8~g/kg) were studied for 24h. :t 17.4
No significant variation was observed for plasma T4 or T3. A significant plasma TSH decrease was shown 4 to 8h after drug administration. Preliminary data on serum FT4 indicate a significant increase at + 2 and + 4h (n = 6).
In conclusion : due to lack of plasma T4 variations, there is no speCIal timing for plasma sampling and T4 determinatioT he transient TSH decreose may underestimate plasma value if blood is taken 4 to 8h after medication. This may be due to FT( elevation related to I-T4 absorption.
